Clinical Trial Update: Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating icotinib in advanced/metastatic non-small cell lung cancer patients previously treated with chemotherapy has completed. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED